Oracle Corporation ORCL Shares Surge on New AI Features in Oracle Fusion Cloud Sales

Oracle Corporation (ORCL) is making waves in the market with its latest advancements in AI technology. The company’s shares are trading higher premarket on Wednesday following the announcement of new AI agents and generative AI features in Oracle Fusion Cloud Sales.

These AI capabilities are set to revolutionize the way sales teams engage with customers, streamline processes, and build stronger relationships. Integrated with Oracle Fusion Cloud Customer Experience (CX), these AI agents will help sales teams automate tasks, optimize emails, and maintain up-to-date records, ultimately boosting productivity and creating more impactful connections with customers.

According to Gartner, B2B sales teams using generative AI are expected to cut prospecting and customer-meeting prep time by over 50% by 2026. This shows the immense potential of AI technology in transforming the sales process and driving efficiency.

In addition to these advancements, Oracle co-founder Larry Ellison recently unveiled plans for an artificial intelligence-driven cancer vaccine system that could deliver personalized treatments within 48 hours. This initiative is part of a larger $500 billion AI infrastructure project called Stargate, a joint venture between Oracle, OpenAI, and SoftBank Group.

Investors looking to gain exposure to Oracle’s stock can consider ETFs such as iShares Expanded Tech-Software Sector ETF (IGV) and FT Vest Technology Dividend Target Income ETF (TDVI).

With all these exciting developments in AI technology and healthcare, Oracle Corporation is definitely a stock to watch. As of the last check on Wednesday, ORCL shares are up 9% at $188.10 premarket. Stay tuned for more updates on this innovative company and its impact on the market.

Photo via Shutterstock.

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.